{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:55:40Z","timestamp":1792526140291,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cmpb.2023.107860","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:01:52Z","timestamp":1697047312000},"page":"107860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Combining pharmacokinetic and electrophysiological models for early prediction of drug-induced arrhythmogenicity"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3958-8062","authenticated-orcid":false,"given":"Jordi","family":"Llopis-Lorente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2941-9499","authenticated-orcid":false,"given":"Samuel","family":"Baroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-9204","authenticated-orcid":false,"given":"K\u00e9vin","family":"Koloskoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-2486","authenticated-orcid":false,"given":"Maria Teresa","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9931-6016","authenticated-orcid":false,"given":"Matthieu","family":"Basset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-8630","authenticated-orcid":false,"given":"Luc\u00eda","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-0825","authenticated-orcid":false,"given":"Javier","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9166-6112","authenticated-orcid":false,"given":"Beatriz","family":"Trenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2023.107860_bib0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart. J."},{"key":"10.1016\/j.cmpb.2023.107860_bib0002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cpt.896","article-title":"Mechanistic model-informed proarrhythmic risk assessment of drugs: review of the \u201cCiPA\u201d initiative and design of a prospective clinical validation study","volume":"103","author":"Vicente","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0003","first-page":"473","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"42","author":"Li","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0004","first-page":"1","article-title":"Open-access database of literature derived drug-related Torsade de Pointes cases","volume":"23","author":"Krumpholz","year":"2022","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12793\/tcp.2019.27.1.12","article-title":"Introduction to in silico model for proarrhythmic risk assessment under the CiPA initiative","volume":"27","author":"Park","year":"2019","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative \u2014 update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cmpb.2023.107860_bib0008","first-page":"2289","article-title":"Assessment of drug proarrhythmicity using artificial neural networks with in silico deterministic model outputs","volume":"0","author":"Yoo","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0009","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/biomedicines11020406","article-title":"Application of convolutional neural networks using action potential shape for in-silico proarrhythmic risk assessment","volume":"11","author":"Jeong","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cmpb.2023.107860_bib0010","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jcim.0c00201","article-title":"In silico classifiers for the assessment of drug proarrhythmicity","volume":"60","author":"Llopis-Lorente","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2023.107860_bib0011","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1111\/bph.14786","article-title":"Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias","volume":"176","author":"Passini","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cpt.1184","article-title":"Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative","volume":"105","author":"Li","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00958","article-title":"A heart for diversity: simulating variability in cardiac arrhythmia research","volume":"9","author":"Ni","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.106934","article-title":"Considering population variability of electrophysiological models improves the in silico assessment of drug-induced torsadogenic risk","volume":"221","author":"Llopis-Lorente","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2023.107860_bib0015","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cmpb.2023.107860_bib0016","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","article-title":"Dofetilide dose reductions and discontinuations in women compared with men","volume":"15","author":"Pokorney","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.cmpb.2023.107860_bib0017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9149(02)03378-7","article-title":"Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues","volume":"91","author":"Wolbrette","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0018","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13615","article-title":"Bias in the reporting of sex and age in biomedical research on mouse models","volume":"5","author":"Fl\u00f3rez-Vargas","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.cmpb.2023.107860_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijcard.2017.01.018","article-title":"Under-representation of elderly and women in clinical trials","volume":"232","author":"Vitale","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish investigations of arrhythmia and mortality on dofetilide study group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmpb.2023.107860_bib0021","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"K\u00f8ber","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cmpb.2023.107860_bib0022","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cmpb.2023.107860_bib0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cmpb.2023.107860_bib0024","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acs.jcim.7b00440","article-title":"In silico QT and APD prolongation assay for early screening of drug-induced proarrhythmic risk","volume":"58","author":"Romero","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2023.107860_bib0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fphar.2017.00816","article-title":"Novel two-step classifier for torsades de pointes risk stratification from direct features","volume":"8","author":"Parikh","year":"2017","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0026","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.apsb.2016.04.004","article-title":"PBPK modeling and simulation in drug research and development","volume":"6","author":"Zhuang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cmpb.2023.107860_bib0027","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/FTD.0000000000000490","article-title":"Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetics: a population pharmacokinetic model-based analysis","volume":"40","author":"Goti","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cmpb.2023.107860_bib0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/0886022X.2019.1707098","article-title":"Acquired long QT syndrome in chronic kidney disease patients","volume":"42","author":"Liu","year":"2020","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cmpb.2023.107860_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex Differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cmpb.2023.107860_bib0030","series-title":"Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations","author":"Rosenbaum","year":"2016"},{"key":"10.1016\/j.cmpb.2023.107860_bib0031","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/FTD.0000000000000987","article-title":"Towards precision dosing of clozapine in schizophrenia: external evaluation of population pharmacokinetic models and bayesian forecasting","volume":"44","author":"Lereclus","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cmpb.2023.107860_bib0032","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O\u2019Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0033","series-title":"2016 Computing in Cardiology Conference (CinC)","first-page":"869","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","author":"Dutta","year":"2016"},{"key":"10.1016\/j.cmpb.2023.107860_bib0034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2015.09.003","article-title":"Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy","volume":"96","author":"Passini","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187739","article-title":"Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure","volume":"12","author":"Mora","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmpb.2023.107860_bib0036","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yjmcc.2010.06.005","article-title":"Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts","volume":"49","author":"Gaborit","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0037","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fphys.2012.00360","article-title":"In silico prediction of sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias","volume":"3","author":"Yang","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0038","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1113\/JP273142","article-title":"A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias","volume":"595","author":"Yang","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0039","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1536\/ihj.46.1105","article-title":"Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes","volume":"46","author":"Verkerk","year":"2005","journal-title":"Int. Heart J."},{"key":"10.1016\/j.cmpb.2023.107860_bib0040","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fphys.2017.00917","article-title":"Uncertainty quantification reveals the importance of data variability and experimental design considerations for in silico proarrhythmia risk assessment","volume":"8","author":"Chang","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0041","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fphys.2019.00580","article-title":"Personalized cardiac computational models: from clinical data to simulation of infarct-related ventricular tachycardia","volume":"10","author":"Lopez-Perez","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fphys.2019.00074","article-title":"Optimization of lead placement in the right ventricle during cardiac resynchronization therapy. A simulation study","volume":"10","author":"Carpio","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0043","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1006\/jmcc.2000.1105","article-title":"Inhomogeneous transmural conduction during early ischaemia in patients with coronary artery disease","volume":"32","author":"Taggart","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141573","article-title":"Detailed anatomical and electrophysiological models of human atria and torso for the simulation of atrial activation","volume":"10","author":"Ferrer","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmpb.2023.107860_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105038","article-title":"Analysis of vulnerability to reentry in acute myocardial ischemia using a realistic human heart model","volume":"141","author":"Carpio","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cmpb.2023.107860_bib0046","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1098\/rsta.2008.0283","article-title":"Mathematical models of the electrical action potential of Purkinje fibre cells","volume":"367","author":"Stewart","year":"2009","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.cmpb.2023.107860_bib0047","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s10439-010-9997-2","article-title":"Adaptive macro finite elements for the numerical solution of monodomain equations in cardiac electrophysiology","volume":"38","author":"Heidenreich","year":"2010","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.cmpb.2023.107860_bib0049","first-page":"370","article-title":"A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide","volume":"70","author":"Phillips","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-2125.1999.00068.x","article-title":"Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease","volume":"48","author":"Preechagoon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0051","unstructured":"R\u00e9sum\u00e9 des Caract\u00e9ristiques du Produit, (n.d.). http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0122266.htm (accessed September 15, 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0052","article-title":"Cisapride: a novel gastroprokinetic drug","volume":"44","author":"Arora","year":"1991","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.cmpb.2023.107860_bib0053","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2125.1997.t01-1-00606.x","article-title":"Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method","volume":"44","author":"Jerling","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0054","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2165\/00003088-199222060-00005","article-title":"Pharmacokinetics of quinidine in male patients: a population analysis","volume":"22","author":"Verme","year":"1992","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cmpb.2023.107860_bib0055","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/bcp.13093","article-title":"Population pharmacokinetics of intramuscular droperidol in acutely agitated patients","volume":"82","author":"Foo","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0056","series-title":"Annual Meeting of Population Approach Group in Europe","article-title":"Population pharmacokinetic modelling of pimozide and its relation to CYP2D6 genotype","author":"Nucci","year":"2007"},{"key":"10.1016\/j.cmpb.2023.107860_bib0057","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/11531730-000000000-00000","article-title":"Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders","volume":"49","author":"Thyssen","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cmpb.2023.107860_bib0058","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - ZECLAR 500 mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments, (n.d.). https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=67997205&typedoc=R#RcpPropPharmacocinetiques (accessed 15 September 2023, 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0059","series-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2018"},{"key":"10.1016\/j.cmpb.2023.107860_bib0060","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - RYTHMODAN 250 mg A LIBERATION PROLONGEE, comprim\u00e9 enrob\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments, (n.d.). https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=69235837&typedoc=R#RcpPosoAdmin (accessed 15 September 2023, 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0061","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - RYTHMODAN 100 mg, g\u00e9lule - Base de donn\u00e9es publique des m\u00e9dicaments, (n.d.). https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63063487&typedoc=R#RcpPosoAdmin (accessed 15 September 2023, 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0062","unstructured":"Pfizer Laboratories Div Pfizer Inc, TIKOSYN-dofetilide capsule, (2023). https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=639 (accessed 7 February 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0063","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - ONDANSETRON ARROW 8 mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments, (n.d.). https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63782187&typedoc=R#RcpPropPharmacocinetiques (accessed 15 September 2023, 2023)."},{"key":"10.1016\/j.cmpb.2023.107860_bib0064","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cpdd.43","article-title":"Pharmacokinetics and comparative bioavailability of domperidone suspension and tablet formulations in healthy adult subjects","volume":"3","author":"Helmy","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.cmpb.2023.107860_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clinthera.2011.11.011","article-title":"Pharmacokinetics of vandetanib: three phase I studies in healthy subjects","volume":"34","author":"Martin","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0066","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ckj\/sfab243","article-title":"How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies","volume":"15","author":"Humphrey","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"1","key":"10.1016\/j.cmpb.2023.107860_bib0067","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41430-018-0154-6","article-title":"Review of case reports on hyperkalemia induced by dietary intake: not restricted to chronic kidney disease patients","volume":"73","author":"te Dorsthorst","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.cmpb.2023.107860_bib0068","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied concepts in PBPK modeling: how to build a PBPK\/PD model","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0069","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/clpt.2009.182","article-title":"Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment","volume":"86","author":"Lalonde","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.14573\/altex.2013.3.309","article-title":"In vitro to human in vivo translation - pharmacokinetics and pharmacodynamics of quinidine","volume":"30","author":"Polak","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.cmpb.2023.107860_bib0071","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/psp4.12573","article-title":"Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions","volume":"10","author":"Varshneya","year":"2021","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0072","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jcpt.13762","article-title":"Utilization of mechanistic modelling and simulation to analyse fenspiride proarrhythmic potency \u2013 role of physiological and other non-drug related parameters","volume":"47","author":"Wi\u015bniowska","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116312","article-title":"Prediction of drug pro-arrhythmic cardiotoxicity using a semi-physiologically based pharmacokinetic model linked to cardiac ionic currents inhibition","volume":"457","author":"Zhou","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0074","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1113\/jphysiol.2006.126714","article-title":"Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart","volume":"582","author":"Gaborit","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ahj.2014.07.010","article-title":"Mechanisms of sex and age differences in ventricular repolarization in humans","volume":"168","author":"Vicente","year":"2014","journal-title":"Am. Heart. J."},{"key":"10.1016\/j.cmpb.2023.107860_bib0076","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1542-474X.2003.08411.x","article-title":"Differences between ventricular repolarization in men and women: description, mechanism and implications","volume":"8","author":"Surawicz","year":"2003","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"7","key":"10.1016\/j.cmpb.2023.107860_bib0077","first-page":"690","article-title":"Sex differences in the evolution of the electrocardiographic QT interval with age","volume":"8","author":"Rautaharju","year":"1992","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0078","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fphys.2017.00597","article-title":"Quantitative comparison of effects of dofetilide, sotalol, quinidine, and verapamil between human ex vivo trabeculae and in silico ventricular models incorporating inter-individual action potential variability","volume":"8","author":"Britton","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0079","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmpb.2023.107860_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104444","article-title":"Maastricht antiarrhythmic drug evaluator (MANTA): a computational tool for better understanding of antiarrhythmic drugs","volume":"148","author":"Sutanto","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cmpb.2023.107860_bib0081","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00005344-200304000-00002","article-title":"Comparative effects of clarithromycin on action potential and ionic currents from rabbit isolated atrial and ventricular myocytes","volume":"41","author":"Gluais","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0082","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.vascn.2006.02.005","article-title":"Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs","volume":"54","author":"Chen","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cmpb.2023.107860_bib0083","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(02)01626-6","article-title":"Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes","volume":"444","author":"Gluais","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0084","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"RR","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.cmpb.2023.107860_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pbiomolbio.2005.05.010","article-title":"Recent advances in understanding sex differences in cardiac repolarization","volume":"94","author":"James","year":"2007","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0086","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt.2240","article-title":"Sex-specific classification of drug-induced torsade de pointes susceptibility using cardiac simulations and machine learning","volume":"110","author":"Fogli Iseppe","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0087","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3389\/fphys.2021.708435","article-title":"Sex differences in drug-induced arrhythmogenesis","volume":"12","author":"Peirlinck","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0088","article-title":"Grapefruit flavonoid naringenin sex-dependently modulates action potential in an in silico human ventricular cardiomyocyte model","volume":"11","author":"Sutanto","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cmpb.2023.107860_bib0089","doi-asserted-by":"crossref","first-page":"122","DOI":"10.15420\/aer.2019.8.3","article-title":"Acquired long QT syndrome and electrophysiology of torsade de pointes","volume":"8","author":"El-Sherif","year":"2019","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"10.1016\/j.cmpb.2023.107860_bib0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/340861","article-title":"Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States food and drug administration adverse event reporting system","volume":"35","author":"Shaffer","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cmpb.2023.107860_bib0091","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10157-019-01773-y","article-title":"Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients","volume":"23","author":"Genovesi","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0092","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0093","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0009-9236(95)90038-1","article-title":"Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization","volume":"57","author":"Coz","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2023.107860_bib0094","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vascn.2013.04.007","article-title":"Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment","volume":"68","author":"Elkins","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cmpb.2023.107860_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jat.1395","article-title":"Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs\u2019 cardiotoxic properties","volume":"29","author":"Polak","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0096","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/acs.jcim.9b01085","article-title":"When does the IC50 accurately assess the blocking potency of a drug?","volume":"2020","author":"Gomis-Tena","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2023.107860_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cmpb.2023.107860_bib0098","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cmpb.2023.107860_bib0099","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.636975","article-title":"Relationship between the free and total methotrexate plasma concentration in children and application to predict the toxicity of HD-MTX","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.2042-7158.1982.tb06211.x","article-title":"Tissue and blood concentrations of chloroquine following chronic administration in the rat","volume":"34","author":"Adelusi","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0101","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.drudis.2019.05.016","article-title":"Better prediction of the local concentration\u2013effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development","volume":"24","author":"Polak","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cmpb.2023.107860_bib0102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2009.07.016","article-title":"Ion-channel mRNA-expression profiling: insights into cardiac remodeling and arrhythmic substrates","volume":"48","author":"Nattel","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2023.107860_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056359","article-title":"mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling: a population-based simulation study","volume":"8","author":"Walmsley","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmpb.2023.107860_bib0104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034560","article-title":"Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study","volume":"10","author":"Danielsson","year":"2020","journal-title":"BMJ Open"}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260723005266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260723005266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:26:51Z","timestamp":1759206411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260723005266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":103,"alternative-id":["S0169260723005266"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2023.107860","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining pharmacokinetic and electrophysiological models for early prediction of drug-induced arrhythmogenicity","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2023.107860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107860"}}